Strategic Science & Technologies

A privately held technology company focused on commercializing a novel, patented transdermal administration formula.

A privately held technology company focused on commercializing a novel, patented transdermal administration formula. Currently we are marketing several OTC products available for the treatment of poor circulation in the extremities and have entered into a single product licensing agreement with a major healthcare company.